微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 0.11% | 100.56% | 116.92% | 116/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -0.65% | 98.57% | -104.43% | 117/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 14.66% | 193.44% | 106.68% | 5/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -219.38% | 83.65% | -1019.29% | 150/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -19.6% | 18.77% | 56.92% | 141/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -45.5% | -302.3% | -189.99% | 148/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -15.69% | -493.23% | 98.83% | 143/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -1341.82% | -2070.18% | -5460.8% | 149/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2023-09-30 | -24.13% | -124.05% | -113.35% | 144/159 | 2.36% | 百利天恒 | 186.1% | 行业排名> |
| 2023-06-30 | -11.31% | -152.46% | -383.46% | 137/159 | 1.49% | 百利天恒 | 186.89% | 行业排名> |
| 2023-03-31 | 3.99% | 9.62% | 106.45% | 18/159 | 1.37% | 百利天恒 | 188.56% | 行业排名> |
| 2022-12-31 | -61.83% | 45.88% | -474.09% | 146/159 | 0.84% | 小方制药 | 41.8% | 行业排名> |
| 2022-09-30 | -10.77% | -488.81% | -140.4% | 130/159 | 2.87% | 拓新药业 | 20.51% | 行业排名> |
| 2022-06-30 | -4.48% | -9.54% | -223.08% | 132/159 | 2.21% | 拓新药业 | 19.87% | 行业排名> |
| 2022-03-31 | 3.64% | -39.43% | 103.19% | 22/159 | 1.59% | 拓新药业 | 19.91% | 行业排名> |
| 2021-12-31 | -114.25% | -44.95% | -4224.55% | 146/159 | 0.87% | 小方制药 | 55.57% | 行业排名> |
| 2021-09-30 | 2.77% | -40.69% | 167.73% | 96/159 | 4.45% | 福元医药 | 25.41% | 行业排名> |
| 2021-06-30 | -4.09% | 13.89% | -168.05% | 129/159 | 2.99% | 小方制药 | 34.81% | 行业排名> |
| 2021-03-31 | 6.01% | 6577.78% | 107.63% | 5/159 | 2.48% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | -78.82% | -66.57% | -1787.79% | 141/159 | 3.82% | ST人福 | 6.82% | 行业排名> |
| 2020-09-30 | 4.67% | 178.49% | 198.32% | 75/159 | 3.15% | 小方制药 | 71.99% | 行业排名> |
| 2020-06-30 | -4.75% | -416.3% | -5377.78% | 119/159 | 4.28% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-03-31 | 0.09% | -88.46% | 100.19% | 86/159 | 2.23% | 汇宇制药 | 28.14% | 行业排名> |
| 2019-12-31 | -47.32% | -791.81% | -695.29% | 129/159 | 2.62% | 哈三联 | 27.17% | 行业排名> |
| 2019-09-30 | -5.95% | -224.22% | -546.74% | 103/159 | 7.58% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-06-30 | -0.92% | -145.77% | -217.95% | 108/159 | 5.02% | 中哲精化 | 45.32% | 行业排名> |
| 2019-03-31 | 0.78% | 23.81% | -88.6% | 89/159 | 2.44% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 6.84% | 14.19% | 42.8% | 69/159 | 7.16% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-09-30 | 4.79% | 13.78% | 138.31% | 70/159 | 7.2% | 奥赛康 | 35% | 行业排名> |
| 2018-06-30 | 2.01% | 0.5% | 219.05% | 81/159 | 4.62% | 奥赛康 | 28.15% | 行业排名> |
| 2018-03-31 | 0.63% | -54.35% | -89.48% | 86/159 | 2.57% | 宏源药业 | 21.91% | 行业排名> |
| 2017-12-31 | 5.99% | -57.06% | 42.28% | 77/159 | 9.61% | 奥赛康 | 9.7% | 行业排名> |
| 2017-09-30 | 4.21% | -43.79% | 110.5% | 66/159 | 8.3% | 奥赛康 | 40.69% | 行业排名> |
| 2017-06-30 | 2% | -57.81% | 44.93% | 82/159 | 5.55% | 信立泰 | 25.93% | 行业排名> |
| 2017-03-31 | 1.38% | -25.41% | -90.11% | 55/159 | 2.11% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | 13.95% | -15.86% | 86.25% | 37/159 | 6.11% | 奥赛康 | 12.08% | 行业排名> |
| 2016-09-30 | 7.49% | -24.27% | 58.02% | 39/159 | 5.7% | 一品红 | 31.62% | 行业排名> |
| 2016-06-30 | 4.74% | -26.05% | 156.22% | 40/159 | 3.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-03-31 | 1.85% | -40.71% | -88.84% | 45/159 | 2.69% | 中哲精化 | 54.24% | 行业排名> |